United States · FDA National Drug Code directory
Enoxaparin Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-584_2b6f0c59-240a-48ec-9cef-e55cc4b52274
- Product NDC
- 63323-584
- Form
- INJECTION
- Composition / generic term
- Enoxaparin Sodium
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190423
- Source listing expiry
- 20271231
Source-listed ingredients
- ENOXAPARIN SODIUM — 80 mg/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (63323-584-65) / 1 SYRINGE in 1 BLISTER PACK (63323-584-63) / .8 mL in 1 SYRINGE · 63323-584-65
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →